PHBI (Pharmagreen Biotech) Asset Turnover: 0.01 (As of Jun. 2023)


What is Pharmagreen Biotech Asset Turnover?

Pharmagreen Biotech PHBI Asset Turnover is 0.01 as of Jun. 2023.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Pharmagreen Biotech's Revenue for the three months ended in Jun. 2023 was $0.00 Mil. Pharmagreen Biotech's Total Assets for the quarter that ended in Jun. 2023 was $0.15 Mil. Therefore, Pharmagreen Biotech's Asset Turnover for the quarter that ended in Jun. 2023 was 0.01.

Asset Turnover is linked to ROE % through Du Pont Formula. Pharmagreen Biotech's annualized ROE % for the quarter that ended in Jun. 2023 was 32.24%. It is also linked to ROA % through Du Pont Formula. Pharmagreen Biotech's annualized ROA % for the quarter that ended in Jun. 2023 was -430.36%.

Pharmagreen Biotech  (OTCPK:PHBI) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Pharmagreen Biotech's annulized ROE % for the quarter that ended in Jun. 2023 is

ROE %**(Q: Jun. 2023 )
=Net Income/Total Stockholders Equity
=-0.652/-2.0225
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.652 / 0.004)*(0.004 / 0.1515)*(0.1515/ -2.0225)
=Net Margin %*Asset Turnover*Equity Multiplier
=-16300 %*0.0264*-0.0749
=ROA %*Equity Multiplier
=-430.36 %*-0.0749
=32.24 %

Note: The Net Income data used here is four times the quarterly (Jun. 2023) net income data. The Revenue data used here is four times the quarterly (Jun. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Pharmagreen Biotech's annulized ROA % for the quarter that ended in Jun. 2023 is

ROA %(Q: Jun. 2023 )
=Net Income/Total Assets
=-0.652/0.1515
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.652 / 0.004)*(0.004 / 0.1515)
=Net Margin %*Asset Turnover
=-16300 %*0.0264
=-430.36 %

Note: The Net Income data used here is four times the quarterly (Jun. 2023) net income data. The Revenue data used here is four times the quarterly (Jun. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

Pharmagreen Biotech Asset Turnover Related Terms

Pharmagreen Biotech Asset Turnover Historical Data

* Premium members only.

The historical data trend for Pharmagreen Biotech's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagreen Biotech Asset Turnover Chart

Pharmagreen Biotech Annual Data
Trend Apr08 Apr09 Sep18 Sep19 Sep20 Sep21 Sep22
Asset Turnover
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Pharmagreen Biotech Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.01 0.01

PHBI vs DVLP, CSTF, BLMS: Asset Turnover Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmagreen Biotech Asset Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Pharmagreen Biotech's Asset Turnover falls into.


Pharmagreen Biotech Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Pharmagreen Biotech's Asset Turnover for the fiscal year that ended in Sep. 2022 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Sep. 2022 )/( (Total Assets (A: Sep. 2021 )+Total Assets (A: Sep. 2022 ))/ count )
=0/( (0.373+0.209)/ 2 )
=0/0.291
=0.00

Pharmagreen Biotech's Asset Turnover for the quarter that ended in Jun. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jun. 2023 )/( (Total Assets (Q: Mar. 2023 )+Total Assets (Q: Jun. 2023 ))/ count )
=0.001/( (0.163+0.14)/ 2 )
=0.001/0.1515
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.01 mean?
Pharmagreen Biotech (PHBI) has a Asset Turnover of 0.01 as of Jun. 2023. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Pharmagreen Biotech and its competitors.
Is Pharmagreen Biotech's Asset Turnover too high?
Pharmagreen Biotech's current Asset Turnover is 0.01.
How does Pharmagreen Biotech's Asset Turnover compare to DVLP and CSTF?
Pharmagreen Biotech's Asset Turnover of 0.01 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Drug Manufacturers company?
A good Asset Turnover depends on the Drug Manufacturers industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Pharmagreen Biotech and its competitors. Pharmagreen Biotech's current Asset Turnover is 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagreen Biotech stock overvalued right now?
Pharmagreen Biotech (PHBI) has a current Asset Turnover of 0.01. The current Asset Turnover is 0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Pharmagreen Biotech (PHBI), the current Asset Turnover is 0.01 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmagreen Biotech Business Description

Address 112 North Curry Street, Carson, NV, USA, 89703
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.